+767.2%
CLS vs IVZ
+135.8%
+631.4%
-56.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | IVZ | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.8% | -1.5% | +0.7% | +0.1% |
| 7D | +7.0% | -0.7% | +7.7% | +7.3% |
| 30D | -21.5% | +1.8% | -23.3% | -22.2% |
| 3M | -28.8% | -11.8% | -17.0% | -23.0% |
| 6M | -33.5% | +6.6% | -40.0% | -35.9% |
| YTD | -19.3% | +11.8% | -31.1% | -26.5% |
| 1Y | -23.3% | +24.8% | -48.1% | -34.9% |
| 3Y | +767.2% | +135.1% | +632.1% | +390.7% |
| All | +767.2% | +135.8% | +631.4% | +390.7% |
Cumulative growth
Daily Returns
Daily percentage return beside IVZ.
Daily Out/Under-Performance
Portfolio return minus IVZ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling